GH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice

The impairment of skeletal muscle function is one of the most debilitating least understood co-morbidity that accompanies acromegaly (ACRO). Despite being one of the major determinants of these patients’ poor quality of life, there is limited evidence related to the underlying mechanisms and treatment options. Although growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels are associated, albeit not indisputable, with the presence and severity of ACRO myopathies the precise effects attributed to increased GH or IGF-1 levels are still unclear. Yet, cell lines and animal models can help us bridge these gaps. This review aims to describe the evidence regarding the role of GH and IGF-1 in muscle anabolism, from the basic to the clinical setting with special emphasis on ACRO. We also pinpoint future perspectives and research lines that should be considered for improving our knowledge in the field.

Overview publication

TitleGH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice
DateJanuary 2nd, 2021
Issue nameInternational Journal of Molecular Sciences
Issue numberv22.1 p415
DOI10.3390/ijms22010415
AuthorsBiagetti B & Simó R
MTGsMTG6
Read Read publication